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The integrin leukocyte function–associated antigen-1 (LFA-1)
plays a pivotal role in leukocyte adhesion andmigration, but the
mechanism(s) by which this integrin is regulated has remained
incompletelyunderstood. LFA-1 integrin activity requiresphos-
phorylation of its 2-chain and interactions of its cytoplasmic
tail with various cellular proteins. The -chain is constitutively
phosphorylated andnecessary for cellular adhesion, but how the
-chain regulates adhesion has remained enigmatic. We now
show that substitution of the -chain phosphorylation site
(S1140A) inT cells inhibits the phosphorylation of the function-
ally important Thr-758 in the 2-chain, binding of -actinin
and 14-3-3 protein, and expression of an integrin-activating
epitope after treatment with the stromal cell–derived factor-1.
The presence of this substitution resulted in a loss of cell adhe-
sion and directional cell migration. Moreover, LFA-1 activation
through the T-cell receptor in cells expressing the S1140A
LFA-1 variant resulted in less Thr-758 phosphorylation, -ac-
tinin and talin binding, and cell adhesion. The finding that the
LFA-1 -chain regulates adhesion through the -chain via
specific phosphorylation at Ser-1140 in the -chain has not
been previously reported and emphasizes that both chains are
involved in the regulation of LFA-1 integrin activity.
Integrins are transmembrane heterodimeric receptors that
communicate in two directions across the plasma membrane
and mediate interactions with other cells and the extracellular
environment (1). Integrins can bind ligands, resulting in out-
side-in signaling, whereas inside-out signaling is initiated by
ligand binding to nonintegrin receptors, such as chemokine
receptors or the T-cell receptor (TCR),4 which activate integ-
rins through intracellular signaling (2, 3). The family of leuko-
cyte-specific 2-integrins consists of four members that have a
common2-chain (CD18) and one of the-chains (L, CD11a;
M, CD11b; X, CD11c; and D, CD11d). The leukocyte func-
tion-associated antigen-1 heterodimer (LFA-1, L2, CD11a/
CD18) is primarily expressed on lymphocytes and binds to
intercellular adhesion molecules (ICAMs). Mac-1 (macro-
phage 1 antigen, M2, CD11b/CD18) is enriched in the mye-
loid lineage and is able to bind numerous ligands, among them
ICAMs and complement protein iC3b. Complement receptor 4
(CR4, X2, CD11c/CD18, p150,95) is expressed in mono-
cytes, macrophages, and dendritic cells, as well as in some sub-
sets of activated T and B cells. It is also capable of binding
various ligands, including extracellularmatrixmolecules, cellu-
lar and soluble ligands, and denatured proteins (4, 5).
Integrins exist in at least three different conformations:
closed, extended, and extended open, each of which possesses
different ligand binding affinities and localization in cells.
Integrins can modulate their adhesive properties within sec-
onds. The activity of the integrins is for themain part regulated
by the binding of different proteins to the cytoplasmic tails,
which is mediated by integrin phosphorylation, clustering, and
receptor cross-talk (6, 7).
The leukocyte integrin-chains are constitutively phosphor-
ylated, whereas the 2-chain becomes phosphorylated after
activation through chemokines, the TCR, or phorbol esters
(8–12). The integrin cytoplasmic domains are short and devoid
of catalytic activity. Only a few cytoplasmic proteins have been
found to specifically bind to the integrin -chain cytoplasmic
tails (13), whereas signaling, adaptor, and cytoskeletal linker
proteins, including talin, kindlins, filamin, -actinin, and
14-3-3 proteins, bind to the 2-integrin tails (14). The integrin
-chain cytoplasmic domains contain three conserved regions:
the two NPX(Y/F) sequences and the serine/threonine se-
quence between them. Mutation of the 2-chain threonines
abrogated cell adhesion, but initial experiments did not reveal
phosphorylation of these (15). By using the phosphatase inhi-
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bitor okadaic acid, strong threonine phosphorylation was
observed after activation (9–11). The 2-chain is phosphory-
lated by protein kinase C (PKC) enzymes (16). The phosphory-
lation of Thr-758 on 2 leads to release of bound filamin and
promotes binding of 14-3-3 proteins. Talin can bind both to the
Thr-758 phosphorylated and unphosphorylated chain (17).
The regulation of the association between -actinin and the
2-chain is currently poorly understood, but it has been shown
that -actinin binding is enhanced by the activation of neutro-
phils and T cells (18, 19).
The leukocyte 2-integrin -chains are phosphorylated on
Ser-1140 (L), Ser-1126 (M), and Ser-1158 (X) (see Fig. 1A),
whereas D phosphorylation has not been studied. The
-chain phosphorylation is important for leukocyte adhesion
and intracellular signaling (20–22), but the mechanism(s) has
remained unknown.We have now focused on the LFA-1 integ-
rin and show that through the phosphorylation of the -chain,
it regulates the phosphorylation, conformation, and protein
binding to the 2-chain in a specific manner. When cells
expressed the LFA-1 S1140Amutation, therewas no phosphor-
ylation of the 2-chain on Thr-758, but there was a loss of both
-actinin and 14-3-3 binding and the presence of the integrin
activation-reporter epitope L16 upon treatment with the
chemokine stromal cell–derived factor-1 (SDF-1). Binding
of filamin increased. These mutant cells displayed abrogated
cell adhesion to the LFA-1 ligand ICAM-1 and impaired direc-
tional migration.When LFA-1 S1140Amutated cells were acti-
vated through the TCR, the 2 phosphorylation and the bind-
ing of -actinin to 2 decreased as compared with WT cells,
whereas the presence of the activation epitope L16was reduced
only slightly as compared with WT cells. This decreased cell
adhesion to ICAM-1. The results indicate an important role for
integrin -chains in the modulation of leukocyte functions by
regulating -chain phosphorylation, which results in altered
cytoplasmic protein interactions, followed by changes in adhe-
sion and migration.
Results
Phosphorylation of the LFA-1-chain regulates the
phosphorylation of the2-chain on Thr-758
Cytoplasmic protein interactions with the integrin 2-chain
have been extensively studied, but the regulation of these has
remained incompletely understood. We now show how the
-chain of LFA-1 regulates integrin functions by affecting the
2-chain. We used the J2.7 human Jurkat T cell line express-
ing equal amounts ofWTLFA-1 or LFA-1 containing themuta-
tion S1140A at the known -chain phosphorylation site (Fig.
1B). We have previously shown that this is the only phosphor-
ylation site on the L-chain and that a significant subset
(40%) of L Ser-1140 is phosphorylated in both activated and
nonactivated cells (9, 20).When the phosphorylation site serine
was substituted by alanine, phosphorylation could not be rec-
ognized by a Ser(P)-1140–specific antibody (Fig. 1C). Cells
expressing WT LFA-1 could bind ICAM-1 after activation by
chemokines such as SDF-1 or through theTCR.Cells express-
ing the L S1140A mutant were unable to bind ICAM-1 after
SDF-1 activation and showed much reduced binding after
activation with anti-CD3 (Fig. 1D). WT cells aggregated on an
SDF-1–coated surface and SDF-1–activated cells spread on
ICAM-1, which was not seen with cells expressing the LFA-1
S1140A mutant (Fig. 1E).
Phosphorylation of the 2-chain Thr-758 is seen only after
activation, e.g. by SDF-1 or through the TCR (9–11). In LFA-1
WT expressing cells, there was no phosphorylation of Thr-758
on the 2-chain without activation, but after treatment with
SDF-1 or TCR, a strong label was seen. Importantly, no phos-
phorylation occurred on 2 Thr-758 in cells expressing the L
S1140A mutant -chain activated with SDF-1. In cells acti-
vated through the TCR, a significantly weaker labeling of the
Thr-758 was obtained in mutant cells as compared with WT
cells (Fig. 1, F and G).
Phosphorylation of Ser-1140 on the LFA-1-chain affects the
binding of cytoskeletal proteins to the2-chain
We further tested whether the -chain mutation affects the
interaction with proteins known to bind to the 2-chain and to
be involved in cell adhesion. Fig. 2A shows immunoprecipita-
tions from Jurkat cells under three conditions; nonactivated,
SDF-1–activated, or anti-CD3–activated cells. Western blots
of supernatants showed equal amounts of proteins in WT and
S1140A-expressing cells. Proteins coprecipitatedwith LFA-1 in
the WT and mutant cell line are shown in the IP IB4 lane and
quantified from three separate experiments as shown below
(Fig. 2B). A significantly reduced binding of -actinin and
14-3-3 was seen in SDF-1–activated mutant cells compared
withWT cells. Talin binding was consistently reduced, but not
significantly. Filamin binding was increased. Activation of the
TCR by anti-CD3 resulted in a significant reduction in talin
binding. -Actinin and 14-3-3 binding was reduced, but not
significantly (Fig. 2, A and B).
The most significant difference between L WT and
S1140A-expressing cells after SDF-1 was seen for -actinin
binding to 2. The -actinin–binding site on the LFA-1 integ-
rin has been mapped to the 2-chain amino acids 736–745,
partly overlapping with the talin membrane-proximal binding
site (23) (Fig. 1A). To verify that there is no -actinin-binding
site on L, synthetic peptides of the cytoplasmic chains of L,
L/Ser(P)-1140, 2, or 2/Thr(P)-758 were linked to Sephar-
ose beads, and Jurkat cell lysates were added. Bound proteins
were separated by SDS-PAGE and analyzed by immunoblotting
for-actinin, 14-3-3, and talin (Fig. 2C). In another experiment,
peptides were spotted on a nitrocellulose membrane, and puri-
fied -actinin was added. After extensive washing, protein
binding was determined with specific antibodies. Experiments
verified that -actinin binds to the 2 or 2/Thr(P)-758 pep-
tides but not to L or L/Ser(P)-1140 (Fig. 2D).
To study the differences in LFA-1-mediated adhesion com-
plex formation in cells adhering to the ligand, the complexes
from Jurkat cells binding to coated ICAM-1 or poly-L-lysine
were purified, and their protein content was analyzed. Proteins
found in the adhesion sites of LFA-1 WT-expressing cells and
bound to ICAM-1 included the integrin 2 and L chains,
-actinin, 14-3-3, and talin, after both SDF-1 and anti-CD3
activation. In contrast, ICAM-1 adhesion complexes from
LFA-1 S1140A-expressing cells contained none of the proteins
Integrin-chain regulates the-chain
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found in WT LFA-1–expressing cells activated with SDF-1,
indicating that stable adhesion complexes were not formed
(Fig. 2E). Instead, these proteins were detected in the Western
blotting of unbound cells (Fig. 2F). After anti-CD3 activation of
S1140A-expressing cells, the same proteins were present in the
ICAM-1 adhesion complexes, although less than in WT LFA-
1–expressing cells. The proteins in the adhesion complexes
were quantified from three separate experiments (Fig. 2G). This
result indicates that J2.7 LFA-1 S1140A-expressing cells can
be at least partly activated to bind ligand by anti-CD3, which is
not the case for SDF-1 activation (Figs. 1, D and E, and 2E).
J2.7 Jurkat cells lacking LFA-1 expression did not bind to
ICAM-1, which indicates that binding takes place solely
through LFA-1 (not shown).
A negative charge on both the- and2-chain
phosphorylation sites increases binding of-actinin to LFA-1
Wewere not able to transfect J2.7 cells with the L S1140D
mutant and therefore used COS7 cells, which have been shown
to express functional heterodimeric integrins on their cell sur-
face after transfection with 2-integrins (24). The L-chain is
phosphorylated in COS7 cells on Ser-1140 (20). COS7 cells do
not contain the SDF-1 receptor or TCR, but integrins can be
activated by phorbol esters. PMA activation of COS7 cells
transfectedwithWTLFA-1 led to increasedThr-758phosphor-
ylation on 2 (Fig. 3A) and increased -actinin and 14-3-3
binding (Fig. 3B). COS7 cells were then transfected with WT
L, the nonphosphorylatable S1140A or the S1140D mutant
that mimics phosphorylated Ser-1140. 2 Thr-758 was phos-
phorylated in cells expressing the S1140D mutant but not in
cells expressing S1140A (Fig. 3A). Lysates from PMA-activated
cells were immunoprecipitated with the LFA-1 antibody IB4,
and the precipitates were immunoblotted for-actinin,2, and
L. Binding of -actinin to LFA-1 was reduced in LFA-1
S1140A-expressing cells in accordance with the results from
J2.7 cells. The LFA-1 S1140Dmutation resembled that ofWT
LFA-1 phosphorylated on Ser-1140, supporting the model that
the negative charge on the -chain is important for 2 Thr-758
phosphorylation, enabling stronger-actinin binding (Fig. 3C).
Mutation ofThr-758 to alanine resulted in decreased binding of
-actinin (Fig. 3D). Cells expressing 2 T758D and the S1140A
L-chain were able to bind -actinin; however, binding was
further increased when a negative charge was present on both
chains, represented by cells expressingLWTSer-1140 and2
T758D. L S1140D-expressing cells did not bind -actinin
without PMAactivation (Fig. 3E). This verifies that the negative
charge on the L-chain Ser-1140 is important for 2 Thr-758
phosphorylation and for increased -actinin binding, which
requires the phosphorylated 2 Thr-758.
We then extended the study to another -chain, X2. This
integrin is expressed in myeloid cells. We therefore stably
expressedX2 in themyeloid/erythroleukemic cell line K562.
Activation of these cells with SDF-1 resulted in phosphoryla-
tion of 2 Thr-758 in WT X2-expressing cells, whereas no
phosphorylation of2 Thr-758was detected in cells expressing
the -chain phosphorylationmutant X S1158A (Fig. 3F). This
result further emphasizes the role of -chain phosphorylation
for 2-chain phosphorylation. The double band could mean
that some 2-chains are phosphorylated on additional sites
(16).
Phosphorylation ofL affects the cellular localization of
-actinin and the activation epitope of LFA-1
We next studied whether there is a difference in the localiza-
tion of -actinin in cells expressing LFA-1WT or S1140A. The
cells were activated with SDF-1 or anti-CD3 and allowed to
adhere to ICAM-1, fixed, and stained for2, for-actinin, or by
phalloidin (Fig. 4, A, and B). In cells expressing WT LFA-1,
-actinin localized to the membrane and ruffling edges and
colocalized with 2 and phalloidin both in SDF-1 and anti-
CD3 activated cells (Pearson’s correlation coefficient for2 and
-actinin at the membrane was 0.78 for SDF-1 and 0.70 for
anti-CD3 activation). Colocalization was also seen in anti-
CD3–activated cells expressing the S1140A mutant, but less in
mutant cells activated with SDF-1 where -actinin staining
was more diffused (Pearson’s correlation coefficient for 2 and
-actinin at the membrane was 0.47 for SDF-1 and 0.69 for
anti-CD3 activation).
The effect of L S1140A phosphorylation on LFA-1 activa-
tion was next identified by labeling cells with the NKI-L16 anti-
body recognizing the fully active epitope L16 of LFA-1 (25).
Cells expressing the WT LFA-1 activated with SDF-1 were
strongly positive for the L16 epitope, which was not detected in
the S1140A-expressing cells. In contrast, L16 positivity was
detected after anti-CD3 activation of S1140A-expressing cells
(Fig. 4, C and D).
Phosphorylation of the LFA-1- and-chains and binding of
-actinin are needed for chemotaxis
The linking of integrins to the actin cytoskeleton by-actinin
is important for cell adhesion andmigration (26). Cell adhesion
was studied by transfecting Jurkat cells expressing LFA-1with a
2-peptide containing the -actinin–binding site of 2, which
blocks the interaction between -actinin and the 2-chain but
does not affect talin binding (19). Static adhesion to ICAM-1
was inhibited by 2-peptide transfection into cells activated by
SDF-1, but not by the control peptide (Fig. 5A). To analyze the
role of the -actinin/integrin interaction in migration, Jurkat
Figure 1. Phosphorylation of Ser-1140 onL regulates phosphorylation of2 on Thr-758. A, amino acid sequence of the2,L,M, andX chains with
theknownphosphorylation sites inboldand thebindingdomainsof talin,-actinin, kindling, and14-3-3 indicated.B, J2.7 cells lackingLexpression (control)
or expressing LFA-1 WT or S1140A were stained with 2 (CD18-PE) or L (CD11a-APC) and analyzed by flow cytometry. Mean fluorescence intensity (MFI) is
shown for each graph. C, J2.7 cells expressing LWT or S1140Awere analyzed byWestern blotting and immunoblotted with L/pS1140 or L antibodies.D,
J2.7 cells expressing L WT or S1140A were activated with SDF-1 or anti-CD3 and allowed to adhere to ICAM-1, and bound cells were quantified. E, in the
upper panels, J2.7 cells expressing LWT or L S1140Awere allowed to adhere to a SDF-1–coated surface. In the lower panels, SDF-1–activated cells were
allowed to adhere to ICAM-1 and spread for 1 h. F, lysates of J2.7 cells expressing L WT or S1140A were activated with SDF-1 or anti-CD3, analyzed by
SDS-PAGE, and immunoblotted with 2/Thr(P)-758, 2, L, or actin as a loading control. G, the amount of 2/Thr(P)-758 per 2 was quantified from five
separate experiments. Molecular mass markers (kDa) are shown to the left of the blots. *, p 0.05; ***, p 0.005.
Integrin-chain regulates the-chain
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cells expressing WT LFA-1 or LFA-1 S1140A were allowed to
migrate over an ICAM-1–coated surface toward SDF-1. In
themutant cells, with reduced interaction between the integrin
and -actinin, directional migration was impaired (Fig. 5B and
videos S1 and S2). Cells transfectedwith the2 peptide, but not
the control peptide, were also unable to migrate (Fig. 5B).
Mutant cells were not able to strongly adhere to ICAM-1 and
could bewashed off by pipetting,whichwas not the case forWT
cells. Themutant cells formed extensions but did not spread or
become polarized to the same extent as WT cells and were not
able to move toward the chemokine gradient. Instead they ruf-
fled in different directions, but the cell body remained station-
ary (Fig. 5, C and D). Both the accumulated and euclidean dis-
tances, as well as directionality, were reduced in cells with
impaired -actinin–integrin binding (Fig. 5E).
Discussion
Integrin activity has to be tightly regulated to allow rapid and
precise changes between different activation states. The roles of
the -chain cytoplasmic tails have been extensively studied and
shown to be essential for integrin function. Chemokines, such
as SDF-1, bind to their receptors resulting in phospholipase C
activation followed by signaling through CalDag, Rap1, and
RapL (27). The proximal signaling events from the TCR are
different and include the Lck tyrosine kinase (28), which then
phosphorylates the ZAP-70 kinase, and phospholipase C (27).
PKCenzymesthenbecomeactivatedinbothpathwaysandphos-
phorylate Thr-758 on 2. Phosphorylation of the 2-chain is
known to regulate the affinity for different binding proteins (7).
Filamin binds primarily to the unphosphorylated 2-chain,
whereas 2 phosphorylated on Thr-758 binds 14-3-3 proteins
and initiates intracellular signaling through Tiam1–Rac1 and
inhibitory signaling to 41 (12, 17, 29, 30).
Previous work indicates a regulatory role for the membrane-
proximal part of -chain cytoplasmic domains in integrin reg-
ulation. The proximal portions of both  and  cytoplasmic
domains are -helical and associate with each other (31). The
GFFKRmotif in the -chain is well conserved and is important
in keeping the integrins in a nonadhesive state by interacting by
ionic bonds with the -chain. When this motif is deleted or
mutated, integrins become active (32–37). Binding of talin can
perturb the membrane-proximal association, disrupting the
intersubunit interactions, which results in activation (38, 39). In
fact, most of the known negative regulators of integrins bind to
the conserved membrane-proximal site (40–42).
The -chain membrane distal regions vary in lengths and
sequences, and their roles in integrin activation have been less
defined. Deletion of the membrane distal regions of some
-chains affects cell adhesion and spreading, but similar dele-
tions in other -chains have no effect on adhesion (15, 43–49).
This shows that there are different regulatory roles of themem-
brane distal regions among different integrins. Interestingly,
deletion of the L membrane distal part diminishes talin- and
kindlin-induced integrin conformational change and ligand
binding (50). We have previously shown that 2-integrin
-chain phosphorylation is needed for adhesion after activation
induced by chemokine, ligand, or active Rap1 (20–22). The
regulatory mechanisms have not been known. We now show
that phosphorylation of the -chain of LFA-1 is needed for
2-chain phosphorylation and its protein interactions.
A significant part of the LFA-1 -chain is phosphorylated on
the single site Ser-1140 (9, 20), and mutation of the serine res-
idue to alanine inhibited or reduced phosphorylation of Thr-
758 in the 2-chain. Treatment with the phosphatase inhibitor
okadaic acid increased -chain phosphorylation (9), indicating
that there is a cycle of phosphorylation and dephosphorylation
events of the -chain. This could, in turn, regulate the phos-
phorylation of Thr-758 of the 2-chain, enabling rapid cell
adhesion and deadhesion for example during movement. We
extended the study to include another -chain, X, which is
known to be phosphorylated on Ser-1158 (22). Phosphorylation
of 2 Thr-758 was impaired also in myeloid/erythroid K562
cells expressing X S1158A.
Although activation of cells with both SDF-1 and through
the TCR results in phosphorylation of Thr-758 on 2, differ-
ences were seen between the LFA-1 WT and S1140A-express-
ing cells. LFA-1 2 could not be phosphorylated on Thr-758,
nor bind to ICAM-1 in mutant cells activated with the chemo-
kine, but showed only a reduced phosphorylation compared
withWTafter anti-CD3 activation. This reflects the differences
in signaling downstream of the TCR and chemokine receptor
and indicates that additional factors play a role in the regulation
of 2 phosphorylation. In WT expressing cells, Thr-758 on 2
is readily phosphorylated upon SDF-1 treatment, and S1140D
is functionally similar evidently because of the negative charge
at position Ser-1140.
The S1140A -chain phosphorylation mutation markedly
decreased -actinin binding to the 2-chain and impaired cell
migration toward the SDF-1 chemokine. Decreased binding
was also seen with 14-3-3 and an increase in binding of filamin,
which is most likely a cause of decreased Thr-758 phosphory-
lation in the mutant cell line. There was also a decrease in talin
binding in the mutant cells activated with anti-CD3. Because
the most prominent difference in binding was seen with -ac-
tinin, we investigated this further. -Actinin is essential for cell
migration (26). Phosphorylation of both L and 2 regulated
the binding between -actinin and LFA-1. The strongest bind-
ing occurred when both L Ser-1140 and 2 Thr-758 were
phosphorylated.
Figure 2.-Chain phosphorylation regulates binding of cytoplasmic interaction partners to2 differently. A, lysates of J2.7 cells expressingLWT or
S1140A were not treated or activated with SDF-1 or anti-CD3, immunoprecipitated with the LFA-1 antibody IB4, and immunoblotted for -actinin, 14-3-3,
talin, filamin, 2, or L. B, the amount of coprecipitated proteins per immunoprecipitated 2 was quantified from three separate experiments. C, full-length
cytoplasmic peptides of L, L/Ser(P)-1140, 2, or 2/Thr(P)-758 were bound to beads and Jurkat cell lysate added. Bound proteins were analyzed by
immunoblottingwith indicated antibodies.D, peptideswere spotted onnitrocellulose, andpurified-actininwas added. Afterwashing, bindingwas assessed
with the -actinin antibody. E and F, J2.7 cells expressing L or L S1140Awere allowed to adhere on poly-L-lysine or ICAM-1 and adhesion complexes (E) or
unbound cells (F) collected, and lysates were analyzed by immunoblotting using indicated antibodies. G, the amount of protein found in the adhesion
complexes was quantified from three separate experiments. SN, supernatant. Molecular mass markers (kDa) are shown to the left of the blots. Lines depict
borders between two separate gels. *, p 0.05; **, p 0.01.
Integrin-chain regulates the-chain
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A negative charge on the L-chain, either by Ser-1140 phos-
phorylation or by expressing the S1140Dmutant, was needed to
enable phosphorylation of the 2 Thr-758. -Actinin was able
to bind the 2-chain also without -chain phosphorylation
only if there was a negative charge on Thr-758, as in the 2
T758Dmutant, which could override the S1140Amutation and
bind -actinin. Binding was, however, stronger with a negative
charge on both chains, indicating that the -chain also directly
regulates -actinin binding. The L cytoplasmic tail forms a
triple-helical structure. Helix 3 makes contacts with both heli-
ces 1 and 2, and helices 1 and 3 are in contact with the 2-tail.
Interestingly, Ser-1140 is located in helix 3 at the negatively
charged surface of the L tail, and its phosphorylation can
enhance the negative charge of this surface (51). We conclude
that L Ser-1140 phosphorylation is required for 2 Thr-758
phosphorylation, possibly by making the site accessible to PKC
enzymes, and as the chains move apart allowing new cytoskel-
etal interactions, as shownby increased-actinin binding. This,
in turn, would have an effect on cytoskeleton-mediated pro-
cesses in cells.
We show that LFA-1 S1140A-expressing cells with impaired
-actinin binding exhibited impaired directional migration
toward the SDF-1 chemokine. Cells expressing the LFA-1
S1140A mutant had a rounded and less polarized morphology
compared with WT expressing cells. The same could be seen
with cells where the 2--actinin interaction was disrupted by
a peptide corresponding to the -actinin–binding site on 2.
This peptide has shown selectivity in binding -actinin and not
talin, although it contains part of the talin membrane-proximal
site (19). Impaired migration in S1140A-expressing cells
appears to be a result of the lack of -actinin linking 2 to the
cytoskeleton, which is known to be important for cell migra-
tion. A conserved region (residues 733–742) in the2 cytoplas-
mic domain is critical for its cytoskeletal association (34). This
region overlaps with the mapped -actinin site (residues 736–
746). Furthermore, a regulatory domain in2 between residues
748–762 inhibits the constitutive association of the2 tail with
-actinin (23). This sequence contains both the Thr-758 phos-
phorylation site and binding sites for talin and 14-3-3. Phos-
phorylation of Ser-1140 on L and Thr-758 on 2 may release
the inhibitory structure of the 2-chain, resulting in -actinin
binding, activation of the integrin binding site as shown with
theNKI-L16 antibody, andmigration of cells.We cannot, how-
ever, rule out the possibility that the reduced migration of
LFA-1 S1140A-expressing cells is due to impaired binding of
other proteins to the -chain. Cells lacking -actinin have a
decreased ability to translocate but adhere more strongly to
ICAM-1 (19). In ourmigration experiment, the LFA-1 S1140A-
expressing cells were able to weakly adhere and make mem-
brane projections but did not migrate toward the chemokine.
This indicates that -actinin may link the active integrin to the
cytoskeleton to mediate directional migration.
At the leading edge, adhesions are constantly turned over,
and the cell membrane attaches and then detaches from
ICAM-1 when making new ligand contacts. Phosphorylation–
dephosphorylation of L Ser-1140 and X Ser-1158 could pro-
vide a fast way of regulating integrin–-actinin cytoskeleton
linkage, dynamic adhesion, and migration. Our data establish
an essential role for the -chain cytoplasmic domain phospho-
rylation in the regulation of the -chain and thus integrin
activity.
Experimental procedures
Reagents and antibodies
Human ICAM-1–Fc and SDF-1 were from R&D Systems
(Minneapolis, MN). The following antibodies were used:
MHM24 (Developmental Studies Hybridoma Bank (DSHB),
Iowa City, IA), anti-CD3 (Immunotools, Friesoythe, Germany),
anti-talin 8d4 (Sigma–Aldrich), mouse anti–-actinin clone
AT6/172 and anti-filamin mAb 1678 (Merck Millipore), rabbit
anti--actinin EP2527Y (Abcam,Cambridge,UK), pan anti-14-
3-3 (Santa Cruz Biotechnology, Dallas, TX); a polyclonal rabbit
antiserum against the 2-chain phosphorylated on Thr-758
was produced by GenicBio Ltd. (Shanghai, China), and NKI-
L16 was from Acris Antibodies. The R2E7B antibody against
human2 was previously described (52). IB4, which recognizes
the heterodimeric forms of 2-integrins, was a gift from M.
Arnaout (Massachusetts General Hospital, Boston, MA). Oka-
daic acid (CAS 78111-17-8) was from Santa Cruz Biotechnol-
ogy, and horseradish peroxidase–linked antibodies against
mouse and rabbit IgG were fromCell Signaling (Danvers, MA).
APC-conjugated mouse secondary antibody was from Immu-
notools. CD11a-APC– and CD18-PE–conjugated antibodies
were from BD Biosciences.
Cell cultures, immunoprecipitation, and immunoblotting
COS7 cells were cultured in Dulbecco’s modified Eagle’s
medium and the human T-cell lymphoma cell line J2.7, which
lacks the L-chain (53), was grown in RPMI 1640 supple-
mented with 10% FBS, 2 mM L-glutamine, and 100 units/ml
penicillin/streptomycin. J2.7 cells expressing WT L or
S1140AL togetherwith2 have been described (7). K562 cells
stably expressingWT X or X S1158A together with 2 have
been previously described (22). K562 cells were cultured in
RPMI medium supplemented with 0.5 mg/ml G418 (Calbi-
ochem/MerckMillipore), 10% FBS, 2 mM L-glutamine, and 100
Figure3.Phosphorylations (negativecharges)onboth the- andthe2-chains regulate-actininbinding toLFA-1.A, COS7cellswere transfectedwith
WT L, L/S1140A, or L/S1140D together with WT 2 and cells activated with PMA or left untreated. Lysates were immunoblotted for 2/Thr(P)-758 or 2,
showing that PMA activation increases 2 Thr-758 phosphorylation inWT L and L/S1140D-expressing cells. B, lysates of PMA-activated cells expressingWT
LFA-1 were immunoprecipitated with the LFA-1 antibody IB4, and precipitates were immunoblotted for -actinin, 14-3-3, 2, or L. C, COS7 cells were
transfectedwith theLWT, or the S1140Aor S1140Dmutant, and2 and lysateswere immunoprecipitatedwith the LFA-1 antibody IB4, andprecipitateswere
immunoblotted for-actinin,2, orL. The amount of coprecipitated-actinin per immunoprecipitated2was quantified from three separate experiments.
D, COS7 cells were transfected with LFA-1 WT or the phosphorylation mutants L/S1140A or 2/T758A; lysates were immunoprecipitated with IB4; and
precipitates were immunoblotted for -actinin, 2, or L. E, COS7 cells were transfected with the WT L, L/S1140A, or L/S1140D and WT 2 or 2/T758D;
activated with PMA; or left untreated and analyzed as above. F, K562 cells were transfected with X WT or the phosphorylation mutant S1158A and 2, and
lysateswere immunoblottedwith2/Thr(P)-758 or2. The amount of2/Thr(P)-758 per2was quantified from three separate experiments. SN, supernatant.
Molecular mass markers (kDa) are shown to the left of the blots. ***, p 0.005.
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units/ml penicillin-streptomycin. The cells were treated with
SDF-1 (50 ng/ml) for 20 min, anti-CD3 (10 g/ml) for 30 min
or left untreated. For immunoblotting with the Thr(P)-758/2
antibody, cells were treated with 1 g/ml of okadaic acid for 5
min. Cells were washed once with cold PBS, lysed on ice in 2%
immunoprecipitation assay buffer (50 mM Tris-HCl, pH 7.8,
150 mM NaCl, 1% Triton X-100, 1% Nonidet P-40, 15 mM
MgCl2, and 5mMEDTA) with protease and phosphatase inhib-
Figure 4. Phosphorylation of L affects -actinin localization. J2.7 cells expressing L WT or S1140A were activated with SDF-1 (A) or anti-CD3 (B),
allowed to adhere to ICAM-1, fixed, and stained for 2, -actinin, and phalloidin. The scale bar represents 10m (C). J2.7 cells lacking L expression (control)
or cells expressing L WT or S1140A were left untreated or activated with SDF-1 or anti-CD3. The cells were stained for 2 (CD18-PE) or NKI-L16–APC
recognizing the activated form of the integrin and analyzed by flow cytometry. Mean fluorescence intensity (MFI) is shown for each graph and quantification
of mean fluorescence intensity from three separate experiments (D). ***, p 0.005.
Figure 5. Phosphorylation of L and -actinin binding affect cell migration toward the chemokine SDF-1. A, J2.7 cells expressing L WT or S1140A
with or without SDF-1 activation transfected with the 2-peptide or control peptide were allowed adhere on ICAM-1, and bound cells were quantified. B,
J2.7 cells expressing L WT or S1140A were allowed to migrate over an ICAM-1 covered surface toward the chemokine SDF-1. Tracks of 15 migrating cells
of one representative experiment are shown. C, bright-field images of migrating J2.7 cells expressing LWT or S1140A at five different time points (pictures
taken at 30-min intervals). The scale bar represents 10 m. D, quantification of polarized and nonpolarized cells from 20 screens. E and F, accumulated and
euclidean distance (E) and directionality of migration (F) were quantified by a chemotaxis andmigration tool for 50 cells from three experiments. **, p 0.01;
***, p 0.005.
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itors (Roche Applied Science) for 30 min. Lysates were centri-
fuged at 20,000  g for 1 h at 4 °C. Prewashed protein G-Sep-
harose beads were added for 2 h at 4 °C. The unbound fraction
wasmixedwith IB4 or-actinin antibody overnight at 4 °C, and
protein G-Sepharose beads for another 2 h at 4 °C. The beads
were washed three times with 1% immunoprecipitation assay
buffer (50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 0.5% Triton
X-100, 0.5% Nonidet P-40, 15 mM MgCl2, and 5 mM EDTA),
and bound proteins were eluted with Laemmli sample buffer,
separated on SDS-PAGE, immunoblotted, and detected using
ECL (Pierce). The figures show one representative picture of at
least three experiments. The amount of coprecipitated proteins
per immunoprecipitated 2 was quantified from three separate
experiments by ImageJ. For the calculation of p values, one-way
analysis of variance (Bonferroni post hoc) or unpaired Student’s
t test was used. The mean standard deviations are given in the
figures.
Adhesion complex isolation
Integrin adhesion complexes were isolated as previously
described (54). Briefly, the Jurkat J2.7 cells (5  106/2.5 ml)
activated with SDF-1 for 15 min or anti-CD3 for 30 min were
allowed to adhere on ICAM-1 (3 g/ml) or poly-L-lysine–
coated (0.01%) 6-cm plates for 1 h. The cells were washed once
with prewarmed RPMI 1640 and 6mM dimethyl 3,3-dithiobis-
propionimidate cross-linker (Fisher Scientific) was added for
15 min in the incubator. 3,3-Dithiobispropionimidate was
quenched with 1 M Tris-HCl, pH 8, for 5 min at room temper-
ature. The cells were carefully washed once with ice-cold PBS
and once with modified radioimmune precipitation assay
buffer (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 5 mM disodium
EDTA, pH 8,0, 5% SDS, 1% Triton X-100, 1% sodium deoxy
cholate). 100 l of adhesion recovery solution (125 mM Tris-
HCl, pH 6.8, 1% SDS, 150 mM DTT) was added, and adhesion
complexes were scraped off and collected. Four volumes of
20 °C acetone were added to each sample, which were stored
at80 °C. Precipitated proteins were centrifuged for 20 min at
160,00 g, and the pellets were resuspended in reducing Laem-
mli sample buffer and heated at 85 °C for 5 min.
Cell transfections
Lwas subcloned into the pcDNA3.1 vector (Thermo Scien-
tific). 2 in the pcDNA3.1 vector was from Addgene (Cam-
bridge, MA) (plasmid 8640 (55); the X WT and X S1158A
mutant in the pcDM8 vector have been described (22). The
mutations S1140A and S1140D in L were introduced by site-
directed mutagenesis (56). All constructs were checked by
sequencing. COS7 cells were transiently cotransfected using
FuGENEHD transfection reagent according to themanufactu-
rer’s instructions (Promega, Madison, WI) and harvested 48 h
after the transfection.
The -actinin–binding site-containing the 2 peptide HLS-
DLREYRRFEKEKLKSC and the 2 cytoplasmic chain peptides
with and without phosphate on Thr-758 C-NNDNPLFK-
SA(pT)-TTVMNPK and C-NNDNPLFKSATTTVMNPKwere
obtained from GenicBio Ltd. (Shanghai, China). As a control,
the P621 peptide VDVDSDGSTDLVIGA was used. The 2
peptide containing the -actinin–binding site or the control
peptide P621 was transfected into J2.7 expressing LFA-1 WT
using Pro-Ject protein transfection reagent kit according to the
manufacturer’s instructions (Thermo Scientific). Briefly, 5 g
of peptide in 50l of PBS was added to 10l of the dried Pierce
reagent tube, incubated for 5 min at room temperature, and
added to 500,000 cells/ml in RPMI 1640 without serum in a
six-well plate. After 4 h, the cells were washed twice with PBS
and stored in RPMI 1640.
Immunofluorescence
Jurkat J2.7 cells were activated with SDF-1 (50 ng/ml) for
20 min or anti-CD3 (10 g/ml) for 30 min and allowed to
adhere on ICAM-1 (6 g/ml) coated 8-well Ibidi chambers
(-Slide 8-well, ibiTreat) for 30 min and fixed in 4% formalde-
hyde for 20 min at 37 °C. The plates were washed twice with
PBS. The cells were stained with primary antibodies against
2 (R2E7B) and -actinin (EP2527Y) and Alexa Fluor 488 or
633 secondary antibodies or TRITC-phalloidin (Invitrogen),
washed, and mounted with Prolong Gold antifade reagent
(Thermo Scientific). The Images were acquired using a Leica
TCS SP8 STED 3XCW3D confocalmicroscope (Wetzlar, Ger-
many) with the HC PL Apo 20/0.75 IMM CORR CS2 (glyc-
erol) objective at room temperature and analyzed with Leica
Application Suite and Fiji (National Institutes of Health). For
colocalization studies, confocal images were automatically ana-
lyzed, and individual cells were manually selected as region of
interest.
Flow cytometry
Jurkat J2.7 cells were activated with SDF-1 (100 ng/ml) or
anti-CD3 (10 g/ml) or left untreated. 1  106 cells per treat-
ment were incubated with NKI-L16 (1:100) or CD18-PE in
Hepes buffer on ice for an hour. APC-conjugated goat anti-
mouse was used as the secondary antibody. Flow data were
acquired using an LSR II flow cytometer (Becton Dickinson)
and analyzed using BD FACSDiva software.
Peptide affinity chromatography and dot blot
Sepharose-conjugated lyophilized peptides L: C-KVGF-
FKRNLKEKMEAGRGVPNGIPAEDSELASGQEAGDPGCL-
KPLHEKDSESGGGKD; phospho-L: C-KVGFFKRNLKEK-
MEAGRGVPNGIPAEDSEQLASGQEAGDPGCLKPLHEKD-
SEpSGGGKD; 2: C-KALIHLSDLREYRRFE-KEKLKSQWN-
NDNPLFKSATTTVMNPKFAES; and phospho-2: C-KAL-
IHLSDLREYRRF-EKEKLKSQWNNDNPLFKSApTTTVMNP-
KFAES (GenicBio Ltd., Shanghai, China) were dissolved in PBS
with 0.01% Triton X-100. 150 million Jurkat JE6.1 cells were
lysed with 2% immunoprecipitation buffer and added to pep-
tide-conjugated beads for 8–12 h on a rotator at 4 °C. The sam-
ples were washed four times with 1% immunoprecipitation
buffer, and bound proteins were detected by immunoblotting.
For dot-blot analyses, 5 g of free peptides were spotted on a
nitrocellulose membrane; filters were blocked with 5%milk for
1 h. 5 g of human -actinin protein (Sigma–Aldrich, A9776)
was added on the peptide spots. The membranes were incu-
bated for 2 h on a shaker in coupling buffer (50 mM Tris, 5 mM
EDTA, pH 8.3), washed twice with TBS, and bound -actinin
was detected with the EP2527Y antibody.
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Cell adhesion andmigration assays
For static adhesion assays, soluble ICAM-1 (6 g/ml) was
coated on flat-bottomed 96-well microtiter plates (NUNC
MaxiSorp, Thermo Scientific) overnight at 4 °C. The plates
were then washed twice with PBS and blocked with 1% heat-
denatured BSA for 1 h. 200,000 J2.7 cells expressing LFA-1
WT or L S1140A/2 with or without activation with
SDF-1 (50 ng/ml) for 20 min or anti-CD3 (10 g/ml) for 30
min were allowed to adhere for 30 min. Unbound cells were
removed by washing three times in PBS, and the bound cells
were lysed and detected using p-nitrophenyl phosphate sub-
strate tablets (Sigma–Aldrich, S0942) dissolved in buffer (50
mM NaCH3COO, pH 5, 1% Triton X-100) at a concentration of
3 mg/ml. 100 l of substrate solution was added to each well
containing lysate and incubated for 45 min at 37 °C. The reac-
tion was stopped with 1 M NaOH, and the reactivity was
detected by measuring absorbance at 405 nm.
For the chemotactic cell migration assay,-slide chemotaxis
chambers (Ibidi, Germany) were used. The assays were per-
formed according to the manufacturer’s instructions. Briefly,
the -Slide chemotaxis slides were coated with 6 g/ml
ICAM-1 at 37 °C for 1 h and washed with PBS. 6 l of cells at a
concentration of 3  106 cells/ml were seeded in the center
chamber of a -slide. Two reservoirs were filled with 60 l of
serum-free RPMI 1640. One of the filling ports was filled with
10l of chemoattractant SDF-1 (1g/ml) solution by remov-
ing 10l of medium from the other port on the same side of the
device. Cell migration was recorded by mounting the -Slide
on the stage of an inverted microscope in a cell incubator. For
the trajectory analysis, pictures were taken every 4 min for 4 h
using the Cell-IQ high content screening microscope (10
lens) (Chip-Man Technologies Ltd., Tampere, Finland). The
cells were tracked with the Fiji ImageJ manual tracking pro-
gram (National Institutes of Health), tracks of 15 cells from one
representative experiment are shown in the figure, and tracks of
50 cells each from three separate experiments were analyzed
with the Chemotaxis and Migration Tools software (Ibidi for
ImageJ). Statistical analyses were performed using one-way
analysis of variance (Bonferroni post hoc) or unpaired Student’s
t test. Mean standard deviations are included in figures.
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Supporting information
LFA-1 integrin α-chain phosphorylation regulates cell adhesion by enabling β2-chain phosphorylation and α-
actinin binding
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Gahmberg*
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Video S1. Migration of Jβ2.7 LFA-1 cells towards SDF-1α injected in the upper right corner.
Video S2. Impaired migration of Jβ2.7 LFA-1 S1140A cells towards SDF-1α injected in the upper right corner.
